Alterations and Co-Occurrence of C-MYC, N-MYC, and L-MYC Expression are Related to Clinical Outcomes in Various Cancers

BACKGROUND AND OBJECTIVES: MYC, also known as an oncogenic reprogramming factor, is a multifunctional transcription factor that maintains induced pluripotent stem cells (iPSCs). Although MYC is frequently upregulated in various cancers and is correlated with a poor prognosis, MYC is downregulated an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Moonjung, Seok, Jaekwon, Saha, Subbroto Kumar, Cho, Sungha, Jeong, Yeojin, Gil, Minchan, Kim, Aram, Shin, Ha Youn, Bae, Hojae, Do, Jeong Tae, Kim, Young Bong, Cho, Ssang-Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Stem Cell Research 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226856/
https://www.ncbi.nlm.nih.gov/pubmed/37105559
http://dx.doi.org/10.15283/ijsc22188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226856/
https://www.ncbi.nlm.nih.gov/pubmed/37105559
http://dx.doi.org/10.15283/ijsc22188

Ejemplares similares